Neuromuscular Disorders and Biphasic Cuirass Ventilation (BCV)

What are Neuromuscular Disorders?

Neuromuscular disorders, many of which are progressive, include a wide range of disorders affecting the peripheral nervous system, which consists of the motor and sensory nerves that connect the brain and spinal cord to the rest of the body. Pulmonary muscle weakness is one predominant condition of these disorders. 

A common thread in the many different types of neuromuscular disorders is respiratory muscle weakness. In all cases, treatment of the underlying neuromuscular disorder is indicated, if feasible.   

Muscle weakness pathways show how weakness in several muscle groups can lead to respiratory illness.

How do we treat Neuromuscular Disorders?

The response of respiratory muscle weakness to specific treatments may vary depending on the specific disease entity. For example, respiratory failure due to conditions such as Guillain-Barré syndrome, myasthenia gravis, polymyositis, and multiple sclerosis may be responsive to disease-specific therapy such that respiratory failure resolves as the underlying disorder improves in response to the therapy. In such cases, ventilatory assistance may only be temporary. In contrast, other neuromuscular disorders are not reversible or may progress despite therapy thereby necessitating full-time ventilatory support and adjunctive aids.  

Respiratory muscle weakness due to neuromuscular disorder can lead to acute and/or chronic ventilatory failure as well as recurrent aspiration and pneumonia. Management, which is largely supportive, can provide symptomatic relief, improve quality of life, and in some instances, prolong life

Due to the number of muscles involved in the maintenance of respiration, neurological disorders may impact several areas of importance for healthy breathing

How does Biphasic Cuirass Ventilation (BCV) assist patients with Neuromuscular Disorders?

BCV supports respiratory function naturally with extra-thoracic negative pressure support of lung inflation. Instead of positive pressure inflating the lungs with an endotracheal tube or tracheostomy, the cuirass shell works with your diaphragm’s natural breathing motion to draw air into the lungs. Using the various modes of Biphasic Cuirass Ventilation provides a flexible and comfortable support tool than can restore lung function while improving quality of life.  

 In patients with respiratory muscle weakness who have an ineffective cough, it is suggested that a routine use of adjuncts to assist coughing for secretion clearance is beneficial therapeutic intervention. Such adjuncts can be used in the chronic setting as well during and/or through recovery from acute respiratory illnesses. 

When the motor nerve function of the respiratory muscles is affected, cough strength decreases and breathing becomes weak. Decreased cough strength increases the risk of pneumonia and aspiration because an effective cough is needed to keep the airways clear. 

BCV provides effective high-frequency chest wall oscillation that generates biphasic changes in transrespiratory pressure without the complications commonly associated with positive-pressure ventilation devices.  

This type of gentle, flexible, multi-option support is why we believe that Biphasic Cuirass Ventilation should be a frontline resource for patients suffering with Neuromuscular Disorders.

Want to get started providing Biphasic Cuirass Ventilation to patients under your care? Or are you enquiring for your own, or a loved ones benefit and feel like Biphasic Cuirass Ventilation may improve your own health? Click the button below to reach out to our team to get more information:


Related Posts

Leave a Reply

Recent Articles

RSV/Bronchilitis, Breathlessness, and Momma’s Baby
Biphasic Cuirass Ventilation and Secretion Clearance
How does Biphasic Cuirass Ventilation (BCV) Impact Residual Capacity (FRC)?

Hayek medical, A Division of United Hayek industries

Hayek Medical, a division of United Hayek Industries specializes in the design, manufacture and sale of non-invasive respiratory devices, in particular using a new and patented method of ventilation to achieve what is known as Biphasic Cuirass Ventilation (BCV). We are the world leader in this relatively new and unique method of ventilation.